Literature DB >> 4027470

Quantification of the characteristics of antagonists exhibiting both competitive antagonism and functional interaction.

I E Hughes, D Mackay.   

Abstract

Null equations have been derived which, when applied to log10 concentration-tissue state curves for an agonist determined in the presence and absence of a competitive antagonist which also exhibits functional interaction, allow quantitation of the characteristics of the competitive and functional interactant effects. Both the affinity constant of the antagonist for its receptors and numerical values characterizing the functional interaction can be obtained. The null equations have been tested in a model system by using a mixture of papaverine hydrochloride (either 5 or 20 microM) and methyl atropine bromide (10 nM) to mimic a competitive antagonist which also shows functional interaction. Agreement between values derived directly and indirectly from the model is good and validates the use of the null equations.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4027470      PMCID: PMC1916751          DOI: 10.1111/j.1476-5381.1985.tb08856.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  2 in total

1.  THE UPTAKE OF ATROPINE AND RELATED DRUGS BY INTESTINAL SMOOTH MUSCLE OF THE GUINEA-PIG IN RELATION TO ACETYLCHOLINE RECEPTORS.

Authors:  W D PATON; H P RANG
Journal:  Proc R Soc Lond B Biol Sci       Date:  1965-08-24

2.  An analysis of functional antagonism and synergism.

Authors:  D Mackay
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

  2 in total
  7 in total

1.  A comparison of effects measured with isotonic and isometric recording: II. Concentration-effect curves for physiological antagonists.

Authors:  R B Barlow; S M Bond; C Grant; D S McQueen; Z Yaqoob
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

2.  In vivo pharmacological resultant analysis reveals noncompetitive interactions between opioid antagonists in the rat tail-withdrawal assay.

Authors:  E A Walker
Journal:  Br J Pharmacol       Date:  2006-10-30       Impact factor: 8.739

3.  Analysis of competitive antagonism when this property occurs as part of a pharmacological resultant.

Authors:  J W Black; V P Gerskowitch; P Leff; N P Shankley
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

4.  Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the alpha- and beta-subtypes.

Authors:  R A Bond; D E Clarke
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

5.  Similarity between mu-opioid receptors in mouse vas deferens and guinea-pig ileum.

Authors:  J Goodall; I E Hughes; D Mackay
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

6.  Quantification of the actions of agonists that simultaneously act on a particular type of receptor and have separate functional interactant properties.

Authors:  J Goodall; I E Hughes; D Mackay
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

7.  Meptazinol has a similar agonist action on opioid receptors in field-stimulated mouse vas deferens and guinea-pig ileum.

Authors:  J Goodall; I E Hughes; D Mackay
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.